TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Change in Severity of Auditory Hallucinations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic factors in locally advanced cervical cancer
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of Failure
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary incontinence score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Ferritinemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of Coughing
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Changes in histone methylation levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Diagnosis of Acute Myocardial Infarction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Progression Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: CR/CRu Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time spent in rapid-eye-movement (REM) sleep
Endpoint domain: Physiological/clinical
Endpoint subdomain: Sleep
Primary endpoint: Number of anticoagulation visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Mortality within 30 days of hospital admission
Endpoint domain: Mortality/survival
Primary endpoint: Arterial Tension
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Patients' perception of post-surgical pain
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Proportional Percent Change in Tumor Size
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Serum level of 25(OH)D
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Total plasma concentration-time data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Patient-ventilator asynchrony - time data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The degree of neuromuscular block by train-of-four-watch monitor - time data
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Serum Eosinophil Cationic Protein (ECP)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Change in moderate-vigorous physical activity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: FIQ Score
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Thermally apparent mottling of the anterior knee
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Core-peripheral temperature difference
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Septin9 Plasma Levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Oxidative stress biomarker
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Depth to the epidural space (cm) from baseline ultrasound
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time required for epidural placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Labor pain at time of 30 minutes after placement is complete
Endpoint domain: Life impact
Endpoint subdomain: Pain
Primary endpoint: Depth of anesthesia according to BIS
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Dose Limiting Toxicity (DLT) Adverse Events
Endpoint domain: Adverse events/effects
Primary endpoint: Prevalence of HPV infections
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Composition of the gut microbiome
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Overall quality of gut preparation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Adjusted Mean Change From Baseline in Morning PEF
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: incidence of moderate or severe symptoms of diarrhea
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Decision to Donate Organ
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Percentage of tablets taken
Endpoint domain: Resource use
Endpoint subdomain: Other resource use
Primary endpoint: Serum hemoglobin A1C
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Resolution of patient symptoms and signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Visual Analog Scale (VAS) Foot Pain Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Accuracy of component placement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Change in glycohemoglobin (HbA1c)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic characterization of monogenic diabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Frequency of total clinical manifestations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: composite reliability of obstetric ultrasound findings
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Departure from scheduled follow-up visits
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Feasibility of telephone assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Interprocedure reliability
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Safety of OMP-54F28
Endpoint domain: Adverse events/effects
Primary endpoint: Change in preoperative well-being assessment
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Per subject clinical cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Per subject microbiological cure rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Changes in memory measures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Change from Baseline Disability Score Level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Exercise Adherence Level
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: incidence of femoral perineural catheter colonization
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of patients free from IUA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: change in frequency of total satisfying sexual activity
Endpoint domain: Life impact
Endpoint subdomain: Sexual functioning
Primary endpoint: Adequacy of symptom control
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: correlation between InterRAI-PC and MD Anderson Symptom Inventory scores
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Anthropometric measures indicative of prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Metabolic biomarkers indicative of prediabetes
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Length of Time to Meet Return To Sport Criteria
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Modification of intestinal inflammation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Change in intestinal microflora composition
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Circulating VEGF levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Mask Comfort
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Mask Performance - Objective
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Mask Performance - Subjective
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Vasoactive Inotropic Score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Brain metabolite concentrations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Physical Activity Engagement
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: percent of excess weight loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Time to persistently negative sputum cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Proportion of Patients with persistently negative sputum cultures
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Immune status variations
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Improvement in Functionality
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Caregiver Depression
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Seropositivity Rate Measured by Neutralization Test (NT)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Likert score scale score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: weight reduction from baseline to 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: number of women receiving a diabetes test per ADA Guidelines in the 6-month post-intervention period
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Percentage of Participants With Technically Successful Implant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: German Zarit Burden Interview (G-ZBI)
Endpoint domain: Life impact
Endpoint subdomain: Societal/carer burden
Primary endpoint: Area Under Curve (AUC) of Total and Free dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Maximum concentration (Cmax) of Total and Free dabigatran
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change of Maximal clot formation (MCF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Neural correlates of fear extinction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Cerebrovascular autoregulation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Segmental Strain
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Relief of medication associated metallic taste
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Adverse events by dose level
Endpoint domain: Adverse events/effects
Primary endpoint: Incidence of prostate cancer (indolent vs aggressive type)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Incidence of prostatitis (acute vs chronic)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Incidence of nodular hyperplasia (benign prostatic hyperplasia)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants That Developed Sepsis After Surgery
Endpoint domain: Adverse events/effects
Primary endpoint: rate of patients presenting SAEs
Endpoint domain: Adverse events/effects
Primary endpoint: rate of patients who discontinue treatment due to any AE
Endpoint domain: Adverse events/effects
Primary endpoint: time to treatment discontinuation due to any AEs
Endpoint domain: Adverse events/effects
Primary endpoint: Non-HDL Cholesterol
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Assessment of pain (VAS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Evaluation of the quality of life
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Functional evaluation for low back pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of surgical oblation procedures with equivalent location of the ablation probe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Patients Who Are Negative for HCV RNA at 3 Months Post-transplant
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Radiographic Cup Osseointegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Radiographic Stem Osseointegration
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Maximum concentration observed
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Leicester Cough Questionnaire (LCQ) score
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Sensitivity and specificity of FlowMet-R
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in the pruritus grading score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Engraftment at 42 days post AD-HSC transplantation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Post Traumatic Stress Disorder Checklist (PCL-5) score
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: symptomatic improvement in St. George's Respiratory Questionnaire (SGRQ)
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Tolerance to Medium Chain Triglyceride (MCT) additive
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number and type of themes for financial burden
Endpoint domain: Resource use
Endpoint subdomain: Societal/carer burden
Primary endpoint: Number and type of themes for body image
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number and type of themes for fertility and future parenthood
Endpoint domain: Life impact
Endpoint subdomain: Personal circumstances
Primary endpoint: Number of Participants with Adequate Understanding of Trial Themes Through Cognitive Interviews
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Oxytocin plasma levels
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Variation from baseline in anterior chamber cell score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Risk of liver toxicity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Liver outcomes
Primary endpoint: Decrease in the severity of acne vulgaris
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: Percentage of change in pupil diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change from Baseline Verbal Pain Scores
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Methacholine reactivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Toxicity related to radiation therapy
Endpoint domain: Adverse events/effects
Primary endpoint: Unified Dyskinesia Rating Scale (UdysRS)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: UPDRS part IV
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neurological outcomes
Primary endpoint: Duration of invasive positive pressure ventilation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Change in Mean Arterial Blood Pressure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Incidence of autologous graft-versus-host disease
Endpoint domain: Adverse events/effects
Primary endpoint: Anal sphincter distensibility
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of Participants experiencing Fragility Fractures and Serious Fall-Related Injuries
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Days Without Delirium
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of Glaucoma
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Diagnostic Accuracy of Spectral Domain OCT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: mortality of Intestinal Ischemia
Endpoint domain: Mortality/survival
Primary endpoint: successful rate of removing urinary catheter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: VTE events
Endpoint domain: Mortality/survival
Primary endpoint: Proportion of participants achieving 90% accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-free survival (PFS) for bevacizumab plus first-generation EGFR-TKIs
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival (PFS) for bevacizumab plus second-generation EGFR-TKIs
Endpoint domain: Mortality/survival
Primary endpoint: Progression-free survival (PFS) for bevacizumab plus third-generation EGFR-TKIs
Endpoint domain: Mortality/survival
Primary endpoint: Bleeding Episode Prevention Success
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Daytime Activity Ratio Estimate
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Endometrial transcriptome profile: mRNA array (fold change)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Endometrial protein concentration of leukemia inhibitory factor (LIF)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Progression-Free Survival (PFS) Rate at 6 Months
Endpoint domain: Mortality/survival
Primary endpoint: Sensitivity and specificity of telomere length qPCR as an ALT detection method
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prognostic value of ALT
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: C-circle assay utility in detecting tumor DNA in serum
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Stone Clearance Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Change from baseline in pain on the Pain Visual Analogue Scale at 6 months
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Venous ulcer cicatrization at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: AUC value of convolutional neural network
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Fibrotic signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Caloric intake (kcal)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change in subjective feeling of hunger and food craving
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: glucose euglycemia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: C-peptide steadiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: insulin steadiness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Overall Image Quality
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Quality criteria of the SLN detection technique
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Modification of habituation in percentage
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Level of resilience
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in ETT Position
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Time from symptom onset to diagnosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Efficacy of Romiplostim in increasing platelet counts
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Safety of Romiplostim
Endpoint domain: Adverse events/effects
Primary endpoint: Transfer accuracy
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Management features of atrial fibrillation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in paravalvular regurgitation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Reduction in the number of hemolysis related transfusions
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Absence of device- and/or procedure-related Serious Adverse Events (SAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Mortality prior to and During the First 90 Days of Dialysis
Endpoint domain: Mortality/survival
Primary endpoint: Number of residual neoplastic tissue detected
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: 7-day Point Prevalence Abstinence at Week 12
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status